Literature DB >> 2143198

High-performance liquid chromatography of the drug fosenopril.

J Kirschbaum1, J Noroski, A Cosey, D Mayo, J Adamovics.   

Abstract

High-performance liquid chromatography was used to determine the purity and impurities of fosinopril, an angiotensin-converting enzyme inhibitor used to treat hypertension. Purity values are determined using a silica column and usually are above 99%. All known possible impurities, including stereoisomeric impurities, can be resolved and quantified by injecting solutions of fosinopril onto three separate columns; silica, strong anion exchange and phenyl. Typical impurity contents total 0.5%. Validation data and a study of properties of fosinopril in solution is included.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2143198     DOI: 10.1016/s0021-9673(01)84192-3

Source DB:  PubMed          Journal:  J Chromatogr


  2 in total

Review 1.  Fosinopril. Clinical pharmacokinetics and clinical potential.

Authors:  H Shionoiri; M Naruse; K Minamisawa; S Ueda; H Himeno; S Hiroto; I Takasaki
Journal:  Clin Pharmacokinet       Date:  1997-06       Impact factor: 6.447

Review 2.  Fosinopril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in essential hypertension.

Authors:  D Murdoch; D McTavish
Journal:  Drugs       Date:  1992-01       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.